We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

1 hedge funds and large institutions have $159K invested in Array Biopharma Inc in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 316 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 318 → 1 (-317)

100% less funds holding in top 10

Funds holding in top 10: 28 → 0 (-28)

100% less capital invested

Capital invested by funds: $10.5B → $159K (-$10.5B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 316

Holders
1
Holders Change
-317
Holders Change %
-99.69%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-28
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
316
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$943M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$890M
3
BlackRock
BlackRock
New York
-$824M
4
RG
Redmile Group
California
-$405M
5
FCM
Farallon Capital Management
California
-$394M
Name Holding Trade Value Shares
Change 		Change in
Stake
FMT
251
First Mercantile Trust
Tennessee
– -$460K -9,924 Closed
PAG
252
Private Advisor Group
New Jersey
– -$420K -9,073 Closed
QSS
253
Quantitative Systematic Strategies
Florida
– -$405K -8,733 Closed
RJFSA
254
Raymond James Financial Services Advisors
Florida
– -$397K -8,572 Closed
GD
255
Grandfield & Dodd
New York
– -$369K -7,965 Closed
MML Investors Services
256
MML Investors Services
Massachusetts
– -$366K -7,899 Closed
JGGDR
257
JGP Global Gestao de Recursos
Brazil
– -$358K -7,724 Closed
LCM
258
Laurion Capital Management
New York
– -$357K -7,700 Closed
PIA
259
Piedmont Investment Advisors
North Carolina
– -$347K -7,479 Closed
CIBC Asset Management
260
CIBC Asset Management
Ontario, Canada
– -$345K -7,445 Closed
MAM
261
Meeder Asset Management
Ohio
– -$341K -7,378 Closed
VCM
262
Vivaldi Capital Management
Illinois
– -$312K -6,738 Closed
SGAM
263
Smith Group Asset Management
Texas
– -$307K -6,620 Closed
Comerica Bank
264
Comerica Bank
Texas
– -$306K -6,618 Closed
LWCFA
265
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
– -$303K -6,550 Closed
FTIOP
266
Fiduciary Trust International of Pennsylvania
Pennsylvania
– -$301K -6,500 Closed
TI
267
Telemetry Investments
New York
– -$301K -6,500 Closed
APP
268
Avantax Planning Partners
Iowa
– -$297K -6,331 Closed
CG
269
Colony Group
Massachusetts
– -$293K -6,320 Closed
RMCM
270
Reynders McVeigh Capital Management
Massachusetts
– -$273K -5,900 Closed
B
271
Bailard
California
– -$264K -5,700 Closed
QOP
272
Quinn Opportunity Partners
Virginia
– -$232K -5,000 Closed
WAM
273
World Asset Management
Michigan
– -$230K -4,966 Closed
CWM
274
Circle Wealth Management
New Jersey
– -$225K -4,850 Closed
HC
275
Henshaw Capital
Massachusetts
– -$225K -4,846 Closed
9 10
11
12 13

ARRY Hedge Fund Activity: Q3 2019 in Review

1 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q3 2019, worth a combined $159K — down 100% from $10.5B a quarter earlier.

Sellers outnumbered buyers: 316 funds closed out of ARRY and 0 opened new positions — a net loss of 316 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $943M sold.

  • 1 institutional investor held Array Biopharma Inc (ARRY) as of Q3 2019, down from 318 in Q2 2019.
  • Funds reported $159K of Array Biopharma Inc stock for Q3 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Array Biopharma Inc positions in Q3 2019 and 316 closed out, a net change of -316 holders.
  • The largest Array Biopharma Inc seller in Q3 2019 was Vanguard Group, an estimated $943M sold.

Based on aggregated 13F filings for Q3 2019.